Product Description
Mechanisms of Action: FGFR Antagonist, PGFR Inhibitor, VEGFR Inhibitor, TK Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Taiko Co
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Hepatocellular Carcinoma
Phase 2: Hepatocellular Carcinoma|Breast Cancer|Gastrointestinal Cancer|Colorectal Cancer
Phase 1: Breast Cancer|Pancreatic Cancer|Plasmacytoma|Lung Cancer|Hepatocellular Carcinoma|Non-Small-Cell Lung Cancer|Prostate Cancer|Multiple Myeloma|Kidney Cancer|Colorectal Cancer|Gastrointestinal Cancer|Oncology Solid Tumor Unspecified
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
JapicCTI-121970 |
JapicCTI-121970 | P1 |
Completed |
Hepatocellular Carcinoma |
2013-03-31 |
|||
JapicCTI-101323 |
JapicCTI-101323 | P1 |
Completed |
Non-Small-Cell Lung Cancer |
2012-03-31 |
|||
JapicCTI-111402 |
JapicCTI-111402 | P1 |
Completed |
Colorectal Cancer |
2010-05-31 |
|||
NCT00024206 |
NCI-2012-02412 | P1 |
Completed |
Oncology Solid Tumor Unspecified |
2003-07-01 |
2020-10-26 |
Primary Endpoints|Treatments |
|
NCT00024063 |
CDR0000068888 | P1 |
Unknown status |
Breast Cancer|Pancreatic Cancer|Plasmacytoma|Lung Cancer|Prostate Cancer|Multiple Myeloma|Kidney Cancer|Colorectal Cancer|Gastrointestinal Cancer |
None |
2019-03-21 |
||
JapicCTI-111403 |
JapicCTI-111403 | P2 |
Completed |
Colorectal Cancer |
2012-12-31 |
|||
JapicCTI-101327 |
JapicCTI-101327 | P2 |
Completed |
Gastrointestinal Cancer |
2012-03-31 |
|||
JapicCTI-101178 |
JapicCTI-101178 | P2 |
Completed |
Breast Cancer |
2011-03-31 |
|||
JapicCTI-111404 |
JapicCTI-111404 | P2 |
Completed |
Breast Cancer |
2011-01-04 |
|||
JapicCTI-101087 |
JapicCTI-101087 | P2 |
Completed |
Hepatocellular Carcinoma |
2010-12-31 |
|||
NCT00784290 |
Taiho132070 | P2 |
Completed |
Hepatocellular Carcinoma |
2010-10-01 |
2019-03-18 |
Treatments |
|
JapicCTI-101354 |
JapicCTI-101354 | P3 |
Terminated |
Hepatocellular Carcinoma |
2016-05-31 |
|||
NCT01465464 |
ORIENTAL | P3 |
Terminated |
Hepatocellular Carcinoma |
2014-06-01 |
2019-03-19 |
Treatments |